These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


110 related items for PubMed ID: 8942010

  • 1. Exercise-induced ventricular tachycardia without demonstrable heart disease in childhood.
    Nagashima M, Baba R, Goto M, Nishabata K, Nagano Y.
    Acta Paediatr Jpn; 1996 Oct; 38(5):495-9. PubMed ID: 8942010
    [Abstract] [Full Text] [Related]

  • 2. Long-term follow-up of idiopathic ventricular arrhythmias in otherwise normal children.
    Tsuji A, Nagashima M, Hasegawa S, Nagai N, Nishibata K, Goto M, Matsushima M.
    Jpn Circ J; 1995 Oct; 59(10):654-62. PubMed ID: 8558749
    [Abstract] [Full Text] [Related]

  • 3. [Mid-term clinical condition and prognosis in adrenergic ventricular tachycardia in children with apparently normal hearts].
    Drago F, Vignati G, Agostino DA, Mauri L, Calzolari A, Figini A, Ragonese P.
    G Ital Cardiol; 1997 Apr; 27(4):349-56. PubMed ID: 9244739
    [Abstract] [Full Text] [Related]

  • 4. Adenosine-sensitive right ventricular tachycardia in children.
    Celiker A, Alehan D, Koçak G, Ozme S, Ozer S.
    Turk J Pediatr; 1997 Apr; 39(1):61-7. PubMed ID: 10868195
    [Abstract] [Full Text] [Related]

  • 5. Verapamil for the suppression of idiopathic ventricular tachycardia of left bundle branch block-like morphology.
    Gill JS, Blaszyk K, Ward DE, Camm AJ.
    Am Heart J; 1993 Nov; 126(5):1126-33. PubMed ID: 8237755
    [Abstract] [Full Text] [Related]

  • 6. Electropharmacologic characteristics and radiofrequency catheter ablation of sustained ventricular tachycardia in patients without structural heart disease.
    Lee SH, Chen SA, Tai CT, Chiang CE, Wu TJ, Cheng CC, Chiou CW, Ueng KC, Wang SP, Chiang BN, Chang MS.
    Cardiology; 1996 Nov; 87(1):33-41. PubMed ID: 8631042
    [Abstract] [Full Text] [Related]

  • 7. Long-term course and clinical characteristics of ventricular tachycardia detected in children by school-based heart disease screening.
    Iwamoto M, Niimura I, Shibata T, Yasui K, Takigiku K, Nishizawa T, Akaike T, Yokota S.
    Circ J; 2005 Mar; 69(3):273-6. PubMed ID: 15731530
    [Abstract] [Full Text] [Related]

  • 8. [Clinical characteristics of ventricular tachycardia and ventricular fibrillation in exercise stress testing].
    Fujiwara M, Asakuma S, Ohhira A, Masutani M, Shimizu E, Mine T, Ohyanagi M, Iwasaki T.
    J Cardiol; 2000 Dec; 36(6):397-404. PubMed ID: 11190583
    [Abstract] [Full Text] [Related]

  • 9. Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy.
    Elliott PM, Sharma S, Varnava A, Poloniecki J, Rowland E, McKenna WJ.
    J Am Coll Cardiol; 1999 May; 33(6):1596-601. PubMed ID: 10334430
    [Abstract] [Full Text] [Related]

  • 10. Optimizing catecholaminergic polymorphic ventricular tachycardia therapy in calsequestrin-mutant mice.
    Katz G, Khoury A, Kurtzwald E, Hochhauser E, Porat E, Shainberg A, Seidman JG, Seidman CE, Lorber A, Eldar M, Arad M.
    Heart Rhythm; 2010 Nov; 7(11):1676-82. PubMed ID: 20620233
    [Abstract] [Full Text] [Related]

  • 11. Idiopathic ventricular tachycardia in infancy and childhood: a multicenter study on clinical profile and outcome. Working Group on Dysrhythmias and Electrophysiology of the Association for European Pediatric Cardiology.
    Pfammatter JP, Paul T.
    J Am Coll Cardiol; 1999 Jun; 33(7):2067-72. PubMed ID: 10362215
    [Abstract] [Full Text] [Related]

  • 12. [Idiopathic recurrent ventricular tachycardia in children: characteristics and long-term prognosis].
    Vignati G, Drago F, Mauri L, Guccione P, Ragonese P, Figini A.
    G Ital Cardiol; 1996 Jul; 26(7):747-55. PubMed ID: 8964317
    [Abstract] [Full Text] [Related]

  • 13. Familial polymorphic ventricular arrhythmias: a quarter century of successful medical treatment based on serial exercise-pharmacologic testing.
    Fisher JD, Krikler D, Hallidie-Smith KA.
    J Am Coll Cardiol; 1999 Dec; 34(7):2015-22. PubMed ID: 10588218
    [Abstract] [Full Text] [Related]

  • 14. [Prediction of long-term efficacy of amiodarone for refractory ventricular tachycardia: clinical significance of electrophysiologic study and Holter monitoring].
    Tsuchiya M, Kasanuki H, Ohnishi S, Hosoda S.
    J Cardiol; 1996 Nov; 28(5):267-76. PubMed ID: 8953400
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Idiopathic sustained left ventricular tachycardia in pediatric patients.
    Yasui K, Shibata T, Yokoyama U, Nishizawa T, Takigiku K, Sakon T, Kobayashi H, Iwamoto M, Niimura I.
    Pediatr Int; 2001 Feb; 43(1):42-7. PubMed ID: 11207998
    [Abstract] [Full Text] [Related]

  • 17. Effectiveness of propranolol added to a type I antiarrhythmic agent for sustained ventricular tachycardia secondary to coronary artery disease.
    Friehling TD, Lipshutz H, Marinchak RA, Stohler JL, Kowey PR.
    Am J Cardiol; 1990 Jun 01; 65(20):1328-33. PubMed ID: 2343820
    [Abstract] [Full Text] [Related]

  • 18. Verapamil-sensitive left anterior fascicular ventricular tachycardia: results of radiofrequency ablation in six patients.
    Nogami A, Naito S, Tada H, Oshima S, Taniguchi K, Aonuma K, Iesaka Y.
    J Cardiovasc Electrophysiol; 1998 Dec 01; 9(12):1269-78. PubMed ID: 9869526
    [Abstract] [Full Text] [Related]

  • 19. Verapamil for ventricular tachycardia.
    Chew HC, Lim SH.
    Am J Emerg Med; 2007 Jun 01; 25(5):572-5. PubMed ID: 17543663
    [Abstract] [Full Text] [Related]

  • 20. The Efficacy of Anti-Arrhythmic Drugs in Children With Idiopathic Frequent Symptomatic or Asymptomatic Premature Ventricular Complexes With or Without Asymptomatic Ventricular Tachycardia: a Retrospective Multi-Center Study.
    Bertels RA, Kammeraad JAE, Zeelenberg AM, Filippini LH, Knobbe I, Kuipers IM, Blom NA.
    Pediatr Cardiol; 2021 Apr 01; 42(4):883-890. PubMed ID: 33515328
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.